0001834445-20-000001.txt : 20201203
0001834445-20-000001.hdr.sgml : 20201203
20201203101453
ACCESSION NUMBER: 0001834445-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20201203
DATE AS OF CHANGE: 20201203
EFFECTIVENESS DATE: 20201203
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Abingworth Clinical Co-Development Fund 2 LP
CENTRAL INDEX KEY: 0001834445
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-382087
FILM NUMBER: 201365956
BUSINESS ADDRESS:
STREET 1: 38 JERMYN STREET
CITY: LONDON
STATE: X0
ZIP: SW1Y 6DN
BUSINESS PHONE: 44 0 20 7534 1508
MAIL ADDRESS:
STREET 1: 38 JERMYN STREET
CITY: LONDON
STATE: X0
ZIP: SW1Y 6DN
D
1
primary_doc.xml
X0708
D
LIVE
0001834445
Abingworth Clinical Co-Development Fund 2 LP
38 JERMYN STREET
LONDON
X0
UNITED KINGDOM
SW1Y 6DN
44 0 20 7534 1508
UNITED KINGDOM
None
None
Limited Partnership
true
2020
-
Abingworth Clinical Co-Development Fund 2 GP LP
50 LOTHIAN ROAD
FESTIVAL SQUARE
EDINBURGH
X0
UNITED KINGDOM
EH3 9WJ
Promoter
General Partner of the Issuer
-
Abingworth LLP
38 JERMYN STREET
LONDON
X0
UNITED KINGDOM
SW1Y 6DN
Promoter
Manager of the Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
2020-11-19
true
true
false
0
Asante Capital Group Advisors LLC
155178
None
None
10 East 53rd St.
12th Floor
New York
NY
NEW YORK
10022
All States
false
Indefinite
207480000
Indefinite
false
22
0
true
0
true
0
true
The General Partner, or an affiliate of the General Partner, will be entitled to receive management fees and performance-based compensation from the Issuer under the Issuer's governing documents.
false
Abingworth Clinical Co-Development Fund 2 LP
/s/ John Heard
John Heard
Director of a Member of GP of GP of the Issuer
2020-12-03